EFFECT OF FOOD ON THE STEADY-STATE PHARMACOKINETICS OF RILPIVIRINE WHEN ADMINISTERED AS A FIXED-DOSE COMBINATION IN HIV-1 INFECTED UGANDAN ADULTS
Phase of Trial: Phase I
Latest Information Update: 01 Oct 2018
At a glance
- Drugs Emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Janssen Pharmaceutica
- 31 Mar 2014 Status changed from not yet recruiting to completed, as per Pan-African Clinical Trials Registry.
- 05 Jun 2013 Planned end date added to 30 Jun 2013 as reported by Pan-African Clinical Trials Registry.
- 14 Feb 2013 New trial record